Clinical Trial Update: Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intraoperative intraperitoneal chemoperfusion for treating minimal residual disease in stage III ovarian cancer and primary peritoneal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: University Hospital, Ghent | Conditions: Ovarian Cancer, Primary Peritoneal Cancer | Phase 2 | Status: COMPLETED